BRIEF-Amgen plans appeal of court ruling that could pave way for Novartis biosimilar
March 19, 2015 at 16:10 PM EDT
March 19 (Reuters) - Amgen Inc : * Says plans to appeal U.S. court ruling that rejected its bid to block
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.